Docetaxel Induced Sclerosing Cholangitis.
Jennifer L
JL
Horsley-Silva
Elizabeth N
EN
Dow
Christine O
CO
Menias
Maxwell L
ML
Smith
Estrella M
EM
Carballido
Keith D
KD
Lindor
Hugo E
HE
Vargas
D058668:Adrenergic alpha-1 Receptor Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D000368:Aged; D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D000813:Anilides / Q000008:administration & dosage / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002227:Carbazoles / Q000008:administration & dosage / Q000009:adverse effects; D000077261:Carvedilol; D015209:Cholangitis, Sclerosing / Q000139:chemically induced*; D000077143:Docetaxel; D000077764:Dronedarone; D004347:Drug Interactions; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009570:Nitriles / Q000008:administration & dosage / Q000627:therapeutic use; D011412:Propanolamines / Q000008:administration & dosage / Q000009:adverse effects; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D014105:Tosyl Compounds / Q000008:administration & dosage / Q000627:therapeutic use
D058668:Adrenergic alpha-1 Receptor Antagonists; D000813:Anilides; D000889:Anti-Arrhythmia Agents; D000970:Antineoplastic Agents; D002227:Carbazoles; D009570:Nitriles; D011412:Propanolamines; D043823:Taxoids; D014105:Tosyl Compounds; D000077261:Carvedilol; D000077143:Docetaxel; C053541:bicalutamide; D016729:Leuprolide; D000077764:Dronedarone; D000638:Amiodarone